Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Mallinckrodt
Merck
Medtronic
McKesson

Last Updated: May 26, 2022

Cannabidiol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for cannabidiol and what is the scope of patent protection?

Cannabidiol is the generic ingredient in one branded drug marketed by Gw Res Ltd and is included in one NDA. There are twenty-one patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Cannabidiol has one hundred and thirty-one patent family members in twenty-five countries.

There are nine drug master file entries for cannabidiol. One supplier is listed for this compound.

Summary for cannabidiol
International Patents:131
US Patents:21
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 9
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 44
Clinical Trials: 296
Patent Applications: 5,818
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in cannabidiol?cannabidiol excipients list
DailyMed Link:cannabidiol at DailyMed
Recent Clinical Trials for cannabidiol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Maryland, BaltimorePhase 2
University of MarylandPhase 2
Sheppard Pratt Health SystemPhase 2

See all cannabidiol clinical trials

US Patents and Regulatory Information for cannabidiol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gw Res Ltd EPIDIOLEX cannabidiol SOLUTION;ORAL 210365-001 Sep 28, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Gw Res Ltd EPIDIOLEX cannabidiol SOLUTION;ORAL 210365-001 Sep 28, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Gw Res Ltd EPIDIOLEX cannabidiol SOLUTION;ORAL 210365-001 Sep 28, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Gw Res Ltd EPIDIOLEX cannabidiol SOLUTION;ORAL 210365-001 Sep 28, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for cannabidiol

Country Patent Number Title Estimated Expiration
Serbia 60708 UPOTREBA KANABIDIOLA U LEČENJU KOMPLEKSA TUBEROZNE SKLEROZE (USE OF CANNABIDIOL IN THE TREATMENT OF TUBEROUS SCLEROSIS COMPLEX) See Plans and Pricing
Slovenia 3206716 See Plans and Pricing
World Intellectual Property Organization (WIPO) 2019207319 See Plans and Pricing
Portugal 3206715 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Mallinckrodt
Harvard Business School
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.